CIK 0001810560 · Non-accelerated filer<br>Smaller reporting company
REVELATION BIOSCIENCES, INC.
Sign in to watch- Ticker
- REVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843898466
- Phone
- 650-800-3717
- Business address
- 4660 LAJOLLA VILLAGE DRIVE, SUITE 100, SAN DIEGO, CA, 92122
- Former names
- Petra Acquisition Inc.
Securities
- REVB Common Stock Nasdaq
- REVBW Warrant Nasdaq
- S-1MEF Other S-1MEF
- DEFA14A Proxy Proxy Materials
- 25-NSE Other Notification of Removal from Listing
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
- NT 10-K Other NT 10-K
- EFFECT Other Notice of Effectiveness
- DEFA14A Proxy Proxy Materials
- EFFECT Other Notice of Effectiveness
- DEFA14A Proxy Proxy Materials
- DEFR14A Other DEFR14A
- DEFA14A Proxy Proxy Materials
- NT 10-Q Other NT 10-Q
- NT 10-Q Other NT 10-Q
- CERT Other Certification
- EFFECT Other Notice of Effectiveness
- 8-A12B Other Registration of Securities
- DRS Other Draft Registration Statement
Page 2 of 2 · 40 filings